Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Holze, Friederike; Gasser, Peter; Müller, Felix; Dolder, Patrick C; Liechti, Matthias E

Holze, Friederike; Gasser, Peter; Müller, Felix; Dolder, Patrick C; Liechti, Matthias E.

Afiliación

Holze F; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Gasser P; Clinic Dr. Peter Gasser, Solothurn, Switzerland.
Müller F; Psychiatric University Hospital, University of Basel, Basel, Switzerland.
Dolder PC; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Liechti ME; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: matthias.liechti@usb.ch.

Biol Psychiatry ; 93(3): 215-223, 2023 02 01.

Article en En | MEDLINE | ID: mdl-36266118

Asunto(s)

Ansiedad; Dietilamida del Ácido Lisérgico; Humanos; Dietilamida del Ácido Lisérgico/uso terapéutico; Ansiedad/tratamiento farmacológico; Trastornos de Ansiedad/terapia; Método Doble Ciego; Estudios Cruzados; Resultado del Tratamiento

Palabras clave

Anxiety; Depression; LSD; Life-threatening-illness; Psychedelics; RCT

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ansiedad / Dietilamida del Ácido Lisérgico Tipo de estudio: Clinical_trials Idioma: En Revista: Biol Psychiatry Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google